We found that arginase activity and expression of the arginase II gene were both increased in the heart of MetS rats by L‐arginine supplementation, possibly accounting for the lack of an effect on cardiac injury despite the anti‐hypertensive effect. The gene discussed is ARG2; the disease is metabolic syndrome.